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Recently, a considerable percentage of patients with valvular heart disease also
have coronary artery disease requiring coronary revascularization during valvular
operation, due to the increasing number of elderly patients in the general population,
the improving safety of coronary artery bypass grafting (CABG), the increasing
incidence of coronary artery disease, and the higher mortality rate after acute
myocardial infarction, an incidence of which may be reduced by CABG.1 Com-
bined valvular heart surgery and CABG had a substantially higher hospital
mortality than those having either procedure alone, which ranged from 7% to 18
%.2-9 Since there have not been many reports about this issue, we reviewed the
clinical results of our 15-year experience of combined valvular heart operations
and coronary revascularization to evaluate the clinical results, and to determine if
co-existing coronary artery disease affected long-term survival. 
Patients’ characteristics
From January 1989 through December 2004, 125 patients underwent valvular
surgery combined with coronary artery bypass grafting at the Yonsei Cardio-
vascular Center, Yonsei University College of Medicine. Mean age of the patients
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INTRODUCTION
MATERIALS AND METHODS
was 63 ± 8.9 (range: 35-78) years, and 86 patients (69%)
were male. Mean ages were 64.7 ± 7.9 (range: 43-78) years
in patients with aortic valve disease, and 60.4 ± 9.7 (range,
35-75) years in patients with mitral valve disease. Preo-
perative clinical diagnosis for coronary artery disease
included acute myocardial infarction (MI) in 6 patients,
unstable angina in 23 patients, stable angina in 34 patients,
previous MI in 16 patients, and 46 patients (37%) were
diagnosed during preoperative evaluation for valvular heart
disease (VHD). Aortic valve disease was present in 61
patients, mitral valve disease in 45 patients, tricuspid valve
disease in 3 patients, and multiple valve disease in 16
patients. Among the sixty-one patients with aortic valve
disease, 52 patients (85%) had severe calcification on the
aortic valve. The etiologies of VHD included rheumatic in
37 patients, degenerative in 52 patients, congenital in 5
patients, chordae rupture or elongation without regional
wall motion abnormality or tethering in 29 patients, and
infective in 2 patients. VHDs of ischemic origin were
excluded from this study. 
Extent and location of valvular disease was determined
by echocardiography, and preoperative coronary arterio-
graphy was performed in all patients over the age of 40
years to assess the extent of coronary artery disease. For
patients under 40 years old, only those who had ischemic
symptoms such as typical chest pain or evidence of ischemia
on preoperative electrocardiogram underwent coronary
angiography. A 60 percent reduction or greater in luminal
diameter of a major coronary artery was considered signi-
ficant disease and an indication for bypass grafting. On this
basis, 48 patients had single vessel involvement, 31 patients
had double vessel involvement, 36 patients had triple
vessel involvement, and 10 patients had left main disease.  
Surgical procedures
In all cases, combined valve operation and coronary reva-
scularization was performed under conventional cardiopul-
monary bypass technique in moderate hypothermia (32-
34˚C). Either antegrade or both antegrade and retrograde
cold blood was administered to elicit cardioplegic arrest,
and the distal anastomoses of saphenous vein grafts were
carried out first, using a monofilament suture with a conti-
nuous running suture technique followed by valve repair or
replacement. In cases of using left internal mammary
artery (LIMA), the anastomosis of LIMA was carried out
after the valve replacement. Mitral valve repair was per-
formed in 28 patients, mostly carried out by annuloplasty
using a Carpentier ring (n = 13) or Duran ring (n = 14), or
a Kay plasty of the commissures (n = 1) with or without
additional complicated reconstructions of valve leaflets or
chordae tendinae. In cases of mitral valve replacement,
subvalvular apparatus of the mitral valve was preserved to
reduce the negative effect of mitral replacement in ventri-
cular geometry and function.
Definitions
The number of diseased vessels was defined as the number
of the three major coronary perfusion territories affected.
The Canadian Cardiovascular Society (CCS) Classifica-
tion was used to define the severity of angina and the New
York Heart Association (NYHA) criteria to define severity
of congestive heart failure. The patients were considered to
have neurologic complication when there was a change in
the brain verified by computed tomography to symptoms
clinically suspected to be of neurologic origin. Periopera-
tive myocardial injury was considered when there were
EKG changes compatible with myocardial injury accom-
panied with either elevated cardiac enzyme or wall motion
abnormality observed on the echocardiography. Hospital
death was defined as mortality that occurred within 30
days after the operation or during the hospitalization. A
cardiac event was defined as recurrent symptoms of angina
or dyspnea, myocardial infarction, or congestive heart
failure that required hospitalization more than once during
the follow-up period.
Statistical analysis
All data was retrospectively collected and statistical data
along with values of continuous variables in the text and
tables were expressed as a mean ± standard deviation. A
comparison of means was conducted using Student’s t-test.
Survival curves were constructed using the Kaplan-Meier
method. Logistic regression analysis helped to examine the
relationship between potential risk factors and in-hospital
mortality. A p value of < 0.05 was considered to be statisti-
cally significant. The statistical package used was SPSS
version 11 (version 11 SPSS, Inc., Chicago, IL, USA).
Among 125 patients, 6 patients had previous open-heart
operations (2 had previous CABG, 1 had MVR, 1 had mitral
valvuloplasty, and 2 had ASD patch repair). Among the
patients who had mitral valve surgery, 19 received a mecha-
nical prosthesis, 7 received a biological prosthesis, and 28
had a mitral valve repair. Among the patients who had aortic
valve surgery, 29 received a mechanical prosthesis, 26
received a biological prosthesis, 4 had an aortic valve repair,
and 2 had a Bentall procedure. Valvular operations per-
formed are described in Table 1. Preoperative mean left
ventricular ejection fraction was 56.9% and 74% of patients
were NYHA functional class III or IV. The distributions of
coronary artery disease according to the age and sex are
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RESULTS
shown in Figs. 1 and 2.
Preoperative risk factors for coronary artery disease in-
cluded diabetes mellitus in 32 patients, hypertension in 60
patients, smoking in 63 patients, obesity in 5 patients, family
history of coronary artery disease in 2 patients, and hyper-
cholesterolemia in 33 patients (Table 2). Seventy-five
percent of patients had a Canadian Class III or IV chest
pain. Coronary revascularization was performed in all
patients with a mean of 2.0 distal grafts/patient. Left internal
mammary artery (IMA) was used in 84 patients (67%),
right IMA in 2 patients, and bilateral IMA in 1 patient.
Intraoperative data are described in Table 3. 
The overall hospital mortality was 4.8 % (6/125 patients).
The causes of early death were low cardiac output due to
left ventricular failure in 4 patients and septic multi-organ
failure in 2 patients. Postoperative complications included
CVA in 2 patients, ARF requiring dialysis in 5 patients, re-
exploration for bleeding in 3 patients, IABP insertion due
to low cardiac output in 2 patients, wound infection in 3
patients, pneumonia in 2 patients, and perioperative MI in
1 patient. Postoperative LV EF increased from 56.9 ± 14.2
to 58.6 ± 11.07% without statistical significance (p = 0.09).
Postoperative Canadian (2.33 ± 0.85 to 1.13 ± 0.45, p <
0.05) and NYHA functional class (2.84 ± 0.60 to 1.29 ±
0.57, p < 0.001) improved significantly. The mean follow-
up duration was 91.4 ± 40.9 months (range: 47-245
months), and late mortality occurred in 4 patients during
the follow-up period. The causes of late deaths were
cardiac related in one patient (sudden death) and non-cardiac
related in 3 patients (CVA, malignancy, and sepsis). Two
patients required a reoperation during the follow-up period,
and the causes of reoperations were residual severe aortic
regurgitation 19 months after aortic valvuloplasty in one
patient and paravalvular leakage of the previous mechani-
cal prosthesis after 86 months of mechanical prosthetic
valve implantation in mitral position in the other patient.
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Table 1. Valvular Operations Performed
Name of operation Number of patients Mechanical Tissue
MVR 20 14 6                   
MVP 25                                
MVP c TAP 3                           
MVR c TAP 6 5 1                  
AVR 55 29 26                  
AVP 4                                 
Bentall 2                               
TAP 2                                 
Double valve 4                          
AVR + MVP 2 
MVR + TVR 1                         
AVR + MVR 1
Triple valve 4 
AVR + MVR + TAP 2                    
AVR + MVP + TAP 1
AVR + MVR + TVR 1
MVR, mitral valve replacement; MVP, mitral valve repair; TAP, tricuspid annuloplasty; AVR, aortic valve replacement; AVP, aortic valve 
repair; TVR, tricuspid valve replacement. 
Fig. 1. Age distribution of coronary artery disease in male patients. Fig. 2. Age distribution of coronary artery disease in female patients.
Three patients developed CVA and 3 patients developed
lung cancer. Among the three patients who developed lung
cancer, 1 patient died and 2 patients are currently undergo-
ing chemotherapy. Six patients were readmitted for cardiac
related problems (recurred angina in 3 patients, congestive
heart failure in 1 patient, and arrhythmia in 2 patients). In
all three patients with recurred angina, a follow-up coronary
angiogram showed patent grafts with progression of native
coronary artery disease that was successfully treated with
medication. Independent predictors of in-hospital death
were age, presence of diabetes, preoperative renal insuffi-
ciency, and prolonged ICU stay (Table 4). Kaplan-Meier
estimated survival rates at 1, 5, and 10 years were 94.4 %,
92.3%, and 89.9%, respectively, and freedom from MACE
(major cardiovascular event) rates at 1, 5, and 10 years were
93.6%, 89.7%, and 76.4%, respectively.
The combined valvular and coronary artery disease is in-
creasing, and the increasing numbers of patients suffering
from such coexisting diseases have been offered cardiac
surgery. The most important reason for this is the aging of
the population of patients being candidates for CABG.4,10
In addition, the operative therapy of patients with combin-
ed valvular and coronary artery disease has evolved signi-
ficantly since the early 1970s when the first cases were
performed and routine coronary angiography was advocated
for all patients with valve disease. 
Approximately 8 percent of patients undergoing cardiac
surgery have combined valvular and coronary artery disease
worldwide.11,12 Even though ischemic symptoms such as
angina are important indicators of coronary artery disease,
angina is a less specific indicator of coronary artery disease
in patients with valvular heart disease than in the general
population. Because ischemic symptoms in patients with
valvular heart disease may have other causes such as left
ventricular chamber enlargement, increased wall stress, or
wall thickening with subendocardial ischemia and right
ventricular hypertrophy.
Currently, ACC/AHA practice guidelines recommend
coronary angiography for preoperative evaluation in pa-
tients with anginal symptoms, other objective evidence of
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Table 2. Preoperative Risk Factors for Coronary Artery 
Disease and Concomitant Disease
No. of patients (%)
Preoperative risk factors 
Diabetes Mellitus 32 (26)
Hypertension 60 (48)
Smoking 63 (50)
Obesity 5 (4)  
Family history 2 (2)
Hypercholesterolemia 33 (26)
Concomitant disease
COPD 18 (14)
CVA 9 (7)
ARF 2 (2)
CRF 13 (10)
AAA 5 (4)
PAOD 20 (16)
S/p PTCA 13 (10)      
EuroSCORE 8.7 ± 5.2     
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular 
accident; ARF, acute renal failure; CRF, chronic renal failure; AAA, abdominal
aortic aneurysm; PAOD, peripheral artery occlusive disease; PTCA,
percutaneous transluminal coronary angioplasty.
Table 3. Intraoperative and Postoperative Data
Variables No. of patients (%)
Surgical time (min) 372.0 ± 78.4 
ACC time (min) 128.5 ± 34.1
CPB time (min) 170.6 ± 47.2
# of distal anastomoses/patient 1.98 ± 1.07
Intubation time (hours) 26.8 ± 44.9
ICU length of stay (days) 3.53 ± 3.41
Hospital length of stay (days) 17.4 ± 16.1
Postop. LV EF (%)
Complications
LCO syndrome 2
ARF 5
Arrhythmia 1
CVA 2
Reop. for bleeding 3
Wound infection 3
Postop. MI 1
Pneumonia 2
UGI bleeding 2
ACC, aortic cross clamping; CPB, cardiopulmonary bypass; ICU, intensive 
care unit; Postop., postoperative; LVEF, left ventricular ejection fraction; LCO,
low cardiac output; ARF, acute renal failure; Reop., reoperation; MI,
myocardial infarction; UGI, upper gastrointestinal.
Table 4. Logistic Regression Model to Predict the In-Hospital
Mortality
Variables OR (95% CI) p value*
Age 1.03 (1.01 - 1.05) < 0.01
Diabetes 1.61 (1.02 - 2.54) 0.04
Renal insufficiency 2.20 (1.07 - 4.56) 0.03
ICU stay, days 4.36 (1.97 - 9.67) < 0.01
OR, odd ratio; CI, confidence interval; ICU, intensive care unit.
*only significant variables (p < 0.05) are listed.
ischemia, decreased LV systolic function, history of coro-
nary artery disease, or coronary risk factors. In asympto-
matic patients, coronary angiography is recommended in
men older than 45 years and women older than 55 years.13
Since 1980, our institute adopted a policy of obtaining
coronary arteriography before valvular operations in pati-
ents over the age of 40 in men and 45 in women, and of
performing CABG and valvular repair or replacement at
the same time. In this study, no patient less than 50 years
old had combined coronary artery disease in women; how-
ever, in male patients, 12% (10/86) of patients were less
than 50 years old, and 4 patients were in their 30s. The
prevalence of premature coronary disease was reported to
be 2-11% of all hospitalized myocardial infarcts described
in the literature.14-18 And in the most recent series, an increase
of incidence, probably due to earlier exposure to some risk
factors, such as smoking habit, hyperlipidemia, and stress
as a result of rapid changing of diet habits, and life-styles
which facilitate development of coronary artery disease in
young patients, have been reported.16-18 Therefore, a coronary
angiography should be considered even in younger patients
with risk factors, especially for men and postmenopausal
women. In addition, less expensive and noninvasive diag-
nostic tools such as multi-detector-row helical computed
tomography (MDCT), a simple, useful, and accurate
method to evaluate concomitant coronary artery disease,
might be a good alternative in these patients, if appro-
priately selected.19,20
In this study, we excluded the patients with ischemic
MR since that is thought to be a different disease entity,
which results in higher mortality. In patients with ischemic
MR, the diseases of the coronary artery and valve are not
combined; rather the valvular heart disease is the result
from the coronary artery disease. Therefore, the result of
valvular heart surgery regardless of the type of surgery is
often affected by the extent or the surgical results of the
coronary artery disease. 
During the study period of fifteen years, 4,276 valvular
and 4,457 coronary operations were performed in our
institute, and only 1.4% of the patients underwent combined
coronary and valvular operations, which is less than other
reported series.11,12 The exact reason was not known; how-
ever, we speculated that it may be because the percutaneous
coronary intervention (PCI) ratio to coronary artery surgery
is higher in our institute, almost 10 to 1, and primary or
secondary PCI might have been tried before or after the
valve operations in some patients with high risks. Also the
cardiologists might have been reluctant to recommend
surgery in these patients because of the high expected
mortality and morbidity especially during 1980s and early
1990s. For example, about 40% of patients with sympto-
matic severe aortic stenosis older than 65 years were never
referred to surgery during the same period. However, the
referring rates in these patients are increasing, and even
though the mortality rate was still higher than the isolated
procedures, this study showed that the clinical results in
these patients were promising with satisfactory long-term
survival.
In this study, the early mortality of the patient was higher
than the patients with isolated valvular or coronary artery
disease, respectively. However, the early surgical results
have been improving since 2000 as a result of improve-
ment of surgical technique, better understanding of myo-
cardial protection, and postoperative management. Among
125 patients, 56 patients (45%) were operated on after the
year 2000, and only 1 of these patients died in the imme-
diate postoperative period (1.8%), which was reduced
from 7.2% (5/69) of mortality rate before 2000. In addition,
the long-term mortality for isolated valvular heart and
coronary artery disease were reported to be 78-92%21-23 and
48-95%24-26 at 10 years, which meant that the long term sur-
vival for concomitant coronary and valve operation is com-
parable to those of isolated coronary or valvular operations.
Therefore, surgical management should be considered for
the primary treatment in patients with a coexisting coronary
artery and valvular heart disease.
Study limitations
Since this was a retrospective study, it suffers from the
potential limitations of any retrospective analysis. Also,
although the results showed comparable mortality and
morbidity with other reported series, our study excluded
patients with ischemic MR, which might have resulted in a
higher mortality and morbidity.
In conclusion, combined coronary and valve operations
can be performed safely with optimal surgical results.
Even though the surgical mortality of coexisting coronary
and valve disease is higher than either isolated coronary or
valvular operations, it does not affect the long-term survival.
Since the prevalence of premature coronary disease is
increasing, coronary angiography should be considered
regardless of age or sex in patients with risk factors for
possible concomitant coronary artery disorders.
This study was supported by Yonsei University Research
Fund of 2007.
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